المؤلفون: Nadal-Serrano, Mercedes, Morancho, Beatriz, Escrivá-de-Romaní, Santiago, Bernadó Morales, Cristina, Luque, Antonio, Escorihuela, Marta, Espinosa-Bravo, Martín, Peg, Vicente, Dijcks, Fred A., Dokter, Wim .H.A, Cortés, Javier, Saura Manich, Cristina, Arribas, Joaquín V, Universitat Autònoma de Barcelona

مصطلحات موضوعية: Breast cancer, HER2, Antibody-drug conjugate, SYD985, T-DM1, Patient-derived xenograft

وصف الملف: application/pdf

Relation: Instituto de Salud Carlos III CB16/12/00449; Instituto de Salud Carlos III PI19/01181; Cancers; Vol. 12 (march 2020); https://ddd.uab.cat/record/227669; urn:10.3390/cancers12030670; urn:oai:ddd.uab.cat:227669; urn:pmid:32183023; urn:pmcid:PMC7139846; urn:oai:pubmedcentral.nih.gov:7139846

الاتاحة: https://ddd.uab.cat/record/227669

المؤلفون: Mercedes Nadal-Serrano, Beatriz Morancho, Santiago Escrivá-de-Romaní, Cristina Bernadó Morales, Antonio Luque, Marta Escorihuela, Martín Espinosa Bravo, Vicente Peg, Fred A. Dijcks, Wim H.A. Dokter, Javier Cortés, Cristina Saura, Joaquín Arribas

المصدر: Cancers; Volume 12; Issue 3; Pages: 670

مصطلحات موضوعية: breast cancer, HER2, antibody-drug conjugate, SYD985, T-DM1, patient-derived xenograft

وصف الملف: application/pdf

Relation: https://dx.doi.org/10.3390/cancers12030670

الاتاحة: https://doi.org/10.3390/cancers12030670

المؤلفون: Banerji, Udai, van Herpen, Carla M. L., Saura, Cristina, Thistiethwaite, Fiona, Lord, Simon, Moreno, Victor, Macpherson, Iain R., Boni, Valentina, Rolfo, Christian, de Vries, Elisabeth G. E., Rottey, Sylvie, Geenen, Jilt, Eskens, Ferry, Gil-Martin, Marta, Mommers, Ellen C., Koper, Norbert P., Aftimos, Philippe

المصدر: Banerji , U , van Herpen , C M L , Saura , C , Thistiethwaite , F , Lord , S , Moreno , V , Macpherson , I R , Boni , V , Rolfo , C , de Vries , E G E , Rottey , S , Geenen , J , Eskens , F , Gil-Martin , M , Mommers , E C , Koper , N P & Aftimos , P 2019 , ' Trastuzumab duocarmazine in locally advanced and metastatic solid tumours and HER2-expressing breast cancer : a phase 1 dose-escalation and dose-expansion ....

مصطلحات موضوعية: ANTIBODY-DRUG CONJUGATE, ANTITUMOR-ACTIVITY, PRECLINICAL PROFILE, SYD985, CARCINOMA, EMTANSINE, SELECTION, HER2

وصف الملف: application/pdf

الاتاحة: https://hdl.handle.net/11370/983382c3-fe23-443a-ae3e-d63fb23cab66
https://research.rug.nl/en/publications/983382c3-fe23-443a-ae3e-d63fb23cab66
https://doi.org/10.1016/S1470-2045(19)30328-6
https://pure.rug.nl/ws/files/98716473/Trastuzumab_duocarmazine_in_locally_advanced_and_metastatic_solid_tumours_and_HER2_expressing_breast_cancer_a_phase_1_dose_escalation_and_dose_expansion_study.pdf

المؤلفون: Iain R. Macpherson, Ferry A.L.M. Eskens, Norbert P Koper, Elisabeth G.E. de Vries, Christian Rolfo, Cristina Saura, Sylvie Rottey, Udai Banerji, Jill J.J. Geenen, Marta Gil-Martin, Philippe Aftimos, Victor Moreno, E.C. Mommers, Simon Lord, Valentina Boni, Carla M.L. van Herpen, Fiona C Thistlethwaite

المساهمون: Guided Treatment in Optimal Selected Cancer Patients (GUTS), Medical Oncology

المصدر: Lancet Oncology, 20(8), 1124-1135. ELSEVIER SCIENCE INC
The lancet oncology
Lancet Oncology, 20(8), 1124-1135. Lancet Publishing Group
Dipòsit Digital de la UB
Universidad de Barcelona
Lancet Oncology, 20, 1124-1135
Lancet Oncology, 20, 8, pp. 1124-1135

مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, SELECTION, Immunoconjugates, Receptor, ErbB-2, ANTITUMOR-ACTIVITY, Metastasis, 0302 clinical medicine, Breast cancer, Trastuzumab, Neoplasms, Clinical endpoint, skin and connective tissue diseases, Middle Aged, Response Evaluation Criteria in Solid Tumors, 030220 oncology & carcinogenesis, Female, Rare cancers Radboud Institute for Health Sciences [Radboudumc 9], medicine.drug, PRECLINICAL PROFILE, medicine.medical_specialty, Maximum Tolerated Dose, CARCINOMA, Antineoplastic Agents, Breast Neoplasms, Càncer de mama, 03 medical and health sciences, All institutes and research themes of the Radboud University Medical Center, Metàstasi, SDG 3 - Good Health and Well-being, Internal medicine, HER2, medicine, Humans, Decompensation, Adverse effect, SYD985, Aged, Dose-Response Relationship, Drug, business.industry, Endometrial cancer, Cancer, medicine.disease, 030104 developmental biology, EMTANSINE, Human medicine, business, ANTIBODY-DRUG CONJUGATE

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b70692fb1a9fc695d8ac5957d5b08452
https://eprints.gla.ac.uk/185727/7/185727.pdf